Andrew Goldsweig to Acute Coronary Syndrome
This is a "connection" page, showing publications Andrew Goldsweig has written about Acute Coronary Syndrome.
Connection Strength
2.202
-
Joseph M, Krishna MM, Ezenna C, Pereira V, Ismayl M, Nanna MG, Bangalore S, Goldsweig AM. Short Versus One-Year Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: an Updated Meta-Analysis. Am J Cardiol. 2025 Feb 15; 237:17-28.
Score: 0.749
-
Mostafa MR, Eid MM, Awad AK, Takla A, Hassan AR, Katamesh BE, AlBarakat MM, Ziada AR, Mohamed S, Al-Azizi KM, Goldsweig AM. Safety and Efficacy of Cangrelor in Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis. Am J Cardiovasc Drugs. 2024 Jan; 24(1):71-81.
Score: 0.699
-
Goldsweig AM, Tak HJ, Alraies MC, Park J, Smith C, Baker J, Lin L, Patel N, O'Neill WW, Basir MB. Mechanical Circulatory Support Following Out-of-Hospital Cardiac Arrest: Insights From the National Cardiogenic Shock Initiative. Cardiovasc Revasc Med. 2021 11; 32:58-62.
Score: 0.571
-
Franco AJ, Krishna MM, Joseph M, Ezenna C, Bakir ZE, Sudo RYU, Wippel CW, Ismayl M, Goldsweig AM, Uthirapathy I. Complete versus culprit-only percutaneous coronary intervention in elderly patients with acute coronary syndrome and multivessel coronary artery disease: A systematic review and meta-analysis. Cardiovasc Revasc Med. 2025 Jan; 70:1-9.
Score: 0.181